These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4038675)

  • 1. Suitability of the P388F mouse lymphoma system for detecting potential carcinogens and mutagens.
    Anderson D; Cross MF
    Food Chem Toxicol; 1985 Jan; 23(1):115-8. PubMed ID: 4038675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. II. Test validation and interpretation.
    Amacher DE; Paillet SC; Turner GN; Ray VA; Salsburg DS
    Mutat Res; 1980 Aug; 72(3):447-74. PubMed ID: 7453708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of 2,4,6-trinitrotoluene in an in vitro mammalian gene mutation assay.
    Styles JA; Cross MF
    Cancer Lett; 1983 Aug; 20(1):103-8. PubMed ID: 6661721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversion in thymidine kinase deficient variants of mouse lymphoma P388.
    Ruddy SM; Hickey I
    Mutat Res; 1989 Nov; 227(3):187-92. PubMed ID: 2478884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mouse lymphoma assay.
    Lloyd M; Kidd D
    Methods Mol Biol; 2012; 817():35-54. PubMed ID: 22147567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for indirect involvement of thymidine kinase in excision repair processes in mouse cell lines.
    McKenna PG; Yasseen AA; McKelvey VJ
    Somat Cell Mol Genet; 1985 May; 11(3):239-46. PubMed ID: 3859020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procarbazine is a potent mutagen at the heterozygous thymidine kinase (tk +/-) locus of mouse lymphoma assay.
    Clive D; Turner N; Krehl R
    Mutagenesis; 1988 Mar; 3(2):83-7. PubMed ID: 3288842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.
    Kirkland D; Reeve L; Gatehouse D; Vanparys P
    Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse lymphoma L5178Y thymidine kinase locus assay of 50 compounds.
    Wangenheim J; Bolcsfoldi G
    Mutagenesis; 1988 May; 3(3):193-205. PubMed ID: 3045481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the L5178Y TK+/- mouse lymphoma forward mutation assay using 42 chemicals.
    Oberly TJ; Bewsey BJ; Probst GS
    Mutat Res; 1984 Feb; 125(2):291-306. PubMed ID: 6700611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cytotoxicity on test results in the L5178Y TK+/- mouse lymphoma assay.
    Oberly TJ; Garriot ML
    Environ Mol Mutagen; 1996; 27(1):75-8. PubMed ID: 8625951
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenic activity of 5 thiazole compounds in the Salmonella/microsome and mouse lymphoma TK+/- assays.
    Cameron TP; Hughes TJ; Kirby PE; Palmer KA; Fung VA; Dunkel VC
    Mutat Res; 1985; 155(1-2):17-25. PubMed ID: 3881663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascorbate is detectably mutagenic in the L5178Y TK+/- cell mutation assay.
    Amacher DE; Paillet SC
    Cancer Lett; 1981 Nov; 14(2):151-8. PubMed ID: 7317878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alkaline single cell gel electrophoresis assay with mouse multiple organs: results with 30 aromatic amines evaluated by the IARC and U.S. NTP.
    Sasaki YF; Fujikawa K; Ishida K; Kawamura N; Nishikawa Y; Ohta S; Satoh M; Madarame H; Ueno S; Susa N; Matsusaka N; Tsuda S
    Mutat Res; 1999 Mar; 440(1):1-18. PubMed ID: 10095124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summary of major conclusions from the 4th IWGT, San Francisco, 9-10 September, 2005.
    Kirkland DJ; Hayashi M; Jacobson-Kram D; Kasper P; MacGregor JT; Müller L; Uno Y
    Mutat Res; 2007 Feb; 627(1):5-9. PubMed ID: 17137830
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of mutations in mouse lymphoma L5178Y cells by ethylmethanesulphonate, benzidine and benzo[a]pyrene.
    Henderson L; Ransome S; Brabbs C; Tinner A; Davies S
    Mutagenesis; 1990; 5 Suppl():27-34. PubMed ID: 2184317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viable chromosomal mutations affecting the TK locus in L5178Y/TK+/- mouse lymphoma cells: the other half of the assay.
    Clive D
    Ann N Y Acad Sci; 1983; 407():253-7. PubMed ID: 6410962
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK +/- -3.7.2C mouse lymphoma cells.
    DeMarini DM; Brock KH; Doerr CL; Moore MM
    Mutat Res; 1987 Mar; 187(3):141-9. PubMed ID: 3821767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenic evaluation of carcinogens and non-carcinogens in the L5178Y/TK assay utilizing postmitochondrial fractions (S9) from normal rat liver.
    Amacher DE; Turner GN
    Mutat Res; 1982 Feb; 97(1):49-65. PubMed ID: 7057798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.